Tonix Pharmaceuticals Holding (TNXP) Exchange Rate Effect (2013 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted Exchange Rate Effect of -$64000.0 for Q2 2026, down 1166.67% on a QoQ basis from $6000.0 in Q1 2026, and down 1500.0% year-over-year from $4571.4 in Q2 2025.
Powered by 
Analysis
Tonix Pharmaceuticals Holding (TNXP) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding has reported Exchange Rate Effect for 14 years, with the latest figure at -$64000.0 in Q2 2026.
- On a quarterly basis, Exchange Rate Effect fell 1500.0% year-over-year to -$64000.0 in Q2 2026; TTM through Jun 2026 was -$76000.0, a 1166.67% decrease from a year earlier, with the FY2025 full-year figure at -$31000.0, down 875.0% from the prior year.
- Exchange Rate Effect was -$64000.0 for Q2 2026 at Tonix Pharmaceuticals Holding, down from $6000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $24000.0 in Q4 2024, with the low at -$64000.0 in Q2 2026.
- Average Exchange Rate Effect over 5 years is -$13176.5, with a median of -$10000.0 recorded in 2023.
- The sharpest annual moves came in 2022 and 2024: Exchange Rate Effect slumped 2400.0% in 2022, then soared 340.0% in 2024.
- Over 5 years, Exchange Rate Effect stood at -$5000.0 in 2022, then sank by 100.0% to -$10000.0 in 2023, then surged by 340.0% to $24000.0 in 2024, then sank by 158.33% to -$14000.0 in 2025, then sank by 357.14% to -$64000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$64000.0 (Q2 2026), $6000.0 (Q1 2026), and -$14000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 5.00 Mn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | -7.00 Mn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | -37.00 Mn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -18.00 Mn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | -4.00 Mn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 11.62 Mn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | 19.84 Mn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | -84,000.00 |
| 10 | Tonix Pharmaceuticals Holding | 220.65 Mn | 220.65 Mn | 12.84 Mn | -64,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -64,000.00 |
| Mar 31, 2026 | 6,000.00 |
| Dec 31, 2025 | -14,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Jun 30, 2025 | -4,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Sep 30, 2024 | -17,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | -4,000.00 |
| Dec 31, 2023 | -10,000.00 |
| Sep 30, 2023 | -12,000.00 |
| Mar 31, 2023 | -43,000.00 |
| Dec 31, 2022 | -5,000.00 |
| Sep 30, 2022 | -20,000.00 |
| Jun 30, 2022 | -24,000.00 |
| Mar 31, 2022 | -25,000.00 |
| Dec 31, 2021 | -10,000.00 |
| Sep 30, 2021 | -13,000.00 |
| Jun 30, 2021 | -7,000.00 |